Home
>
National Drug Code (NDC)
>
Keppra
Keppra - 50474-595-40 - (levetiracetam)
Drug Information of Keppra
| Product NDC: | 50474-595 |
| Proprietary Name: | Keppra |
| Non Proprietary Name: | levetiracetam |
| Active Ingredient(s): | 500 mg/1 & nbsp; levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Keppra
| Product NDC: | 50474-595 |
| Labeler Name: | UCB, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021035 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000424 |
Package Information of Keppra
| Package NDC: | 50474-595-40 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-595-40) |
NDC Information of Keppra
| NDC Code | 50474-595-40 |
| Proprietary Name | Keppra |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-595-40) |
| Product NDC | 50474-595 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levetiracetam |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000424 |
| Marketing Category Name | NDA |
| Labeler Name | UCB, Inc. |
| Substance Name | LEVETIRACETAM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
